Vulnerability · Published Jan 21, 2022 · Assigned by icscert
CVE-2021-23233Fresenius Kabi Agilia Connect Infusion System
High 7.3
In plain English
A high-severity improper access control in Agilia Link+ from Fresenius Kabi. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.9% (higher than 61% of all known vulnerabilities).
Severity (CVSS 3.1)7.3High
Exploit odds (30 days)0.9%top 38.7% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
Sensitive endpoints in Fresenius Kabi Agilia Link+ v3.0 and prior can be accessed without any authentication information such as the session cookie. An attacker can send requests to sensitive endpoints as an unauthenticated user to perform critical actions or modify critical configuration parameters.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| Fresenius Kabi | Agilia Link+ | unspecified – before 3.0 |
Weakness: CWE-284 · Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
References
- https://www.cisa.gov/uscert/ics/advisories/icsma-21-355-01 x_refsource_MISC